| Integrating glutathione metabolism and mitochondrial dysfunction with implications for Parkinson’s disease: a dynamic model S Vali, RB Mythri, B Jagatha, J Padiadpu, KS Ramanujan, JK Andersen, ... Neuroscience 149 (4), 917-930, 2007 | 107 | 2007 |
| Complete Genome Sequences of a Mycobacterium smegmatis Laboratory Strain (MC2 155) and Isoniazid-Resistant (4XR1/R2) Mutant Strains A Mohan, J Padiadpu, P Baloni, N Chandra Genome announcements 3 (1), e01520-14, 2015 | 81 | 2015 |
| Network approaches to drug discovery N Chandra, J Padiadpu Expert opinion on drug discovery 8 (1), 7-20, 2013 | 47 | 2013 |
| Identifying and tackling emergent vulnerability in drug-resistant mycobacteria J Padiadpu, P Baloni, K Anand, MH Munshi, C Thakur, A Mohan, A Singh, ... ACS infectious diseases 2 (9), 592-607, 2016 | 32 | 2016 |
| Microbiota and adipocyte mitochondrial damage in type 2 diabetes are linked by Mmp12+ macrophages Z Li, M Gurung, RR Rodrigues, J Padiadpu, NK Newman, NP Manes, ... Journal of Experimental Medicine 219 (7), e20220017, 2022 | 26 | 2022 |
| Protein–protein interaction networks suggest different targets have different propensities for triggering drug resistance J Padiadpu, R Vashisht, N Chandra Systems and synthetic biology 4, 311-322, 2010 | 26 | 2010 |
| Identifying feasible metabolic routes in Mycobacterium smegmatis and possible alterations under diverse nutrient conditions P Baloni, J Padiadpu, A Singh, KR Gupta, N Chandra BMC microbiology 14, 1-15, 2014 | 25 | 2014 |
| Reducing gut microbiome-driven adipose tissue inflammation alleviates metabolic syndrome NK Newman, Y Zhang, J Padiadpu, CL Miranda, AA Magana, CP Wong, ... Microbiome 11 (1), 208, 2023 | 6 | 2023 |
| Probing the druggability limits for enzymes of the NAD biosynthetic network in glioma J Padiadpu, M Mishra, E Sharma, U Mala, K Somasundaram, N Chandra Journal of Chemical Information and Modeling 56 (5), 843-853, 2016 | 5 | 2016 |
| Gene expression profiles of wild-type and isoniazid-resistant strains of Mycobacterium smegmatis J Padiadpu, P Baloni, N Chandra Data in Brief 4, 186-189, 2015 | 5 | 2015 |
| Rationalization and prediction of drug resistant mutations in targets for clinical anti-tubercular drugs J Padiadpu, S Mukherjee, N Chandra Journal of Biomolecular Structure and Dynamics 31 (1), 44-58, 2013 | 5 | 2013 |
| Multi-omic network analysis identified betacellulin as a novel target of omega-3 fatty acid attenuation of western diet-induced nonalcoholic steatohepatitis J Padiadpu, M Garcia-Jaramillo, N Newman, J Pederson, R Rodrigues, ... EMBO Mol Med 15 (e18367), 2023 | 2 | 2023 |
| Early transcriptome changes associated with western diet induced NASH in Ldlr-/-mice points to activation of hepatic macrophages and an acute phase response. J Padiadpu, MH Spooner, Z Li, N Newman, DK Apperson, CV Löhr, ... Front. Nutr., 07 August 2023 Sec. Nutrigenomics 10, 2023 | 2 | 2023 |
| Metabolic Network Analysis: Implication And Application RSDS Syed Asad Rahman, Pardha Saradhi Jonnalagadda, Jyothi Padiadpu, Kai ... BMC Bioinformatics 6 (S12), 2005 | 2 | 2005 |
| Suppression of Betacellulin expression is a key mechanism for omega-3 fatty acid mediated attenuation of nonalcoholic steatohepatitis J Padiadpu, M Garcia-Jaramillo, N Newman, J Pederson, R Rodrigues, ... bioRxiv, 2022 | 1 | 2022 |
| Transkingdom Network Analysis (TkNA): a systems framework for inferring causal factors underlying host–microbiota and other multi-omic interactions NK Newman, MS Macovsky, RR Rodrigues, AM Bruce, JW Pederson, ... Nature Protocols, 1-29, 2024 | | 2024 |
| Intestinal IL-22RA1 signaling regulates intrinsic and systemic lipid and glucose metabolism to alleviate obesity-associated disorders SJ Gaudino, A Singh, H Huang, J Padiadpu, M Jean-Pierre, C Kempen, ... Nature Communications 15 (1), 1597, 2024 | | 2024 |
| An Integrated Systems Biology Approach to Study Drug Resistance in Mycobacteria J Padiadpu | | 2018 |
Nagasuma ChandraIndian Institute of ScienceVerified email at iisc.ac.in
